GlassScriptPhysician profile
Amy Elizabeth Smith
NPI 1952986127
$3,734.64
in general payments reported to CMS, 2019-2025
25 companies · $743 in 2025
The $743 reported for 2025 was more than what 92% of Registered Nurse providers received nationally (typical 2025 total: $73.55).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $243 · 2023: $808 · 2024: $1,941 · 2025: $743.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,492.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,491.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $733.50 | 2023-2025 | |
| Collegium Pharmaceutical, INC. | $653.18 | 2022-2025 | Xtampza, Belbuca |
| Scilex Pharmaceuticals INC. | $577.73 | 2022-2025 | Ztlido |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $499.37 | 2024-2025 | Relistor |
| Protega Pharmaceutials INC | $292.11 | 2023-2025 | Roxybond |
| Electronic Waveform Lab, INC. | $116.49 | 2022-2024 | |
| Vertos Medical, INC. | $99.33 | 2024 | Mild Device Kit |
| Averitas Pharma INC. | $95.66 | 2023-2025 | Qutenza |
| Glaxosmithkline, LLC. | $83.86 | 2024-2025 | Jemperli, Zejula |
| Mallinckrodt Hospital Products INC. | $69.50 | 2024 | Acthar |
| Biotronik Nro, INC. | $66.87 | 2024-2025 | Prospera |
| Vertex Pharmaceuticals Incorporated | $66.70 | 2024-2025 | |
| Boston Scientific Corporation | $52.95 | 2022-2023 | Wavewriter Alpha Prime 16 |
| Curonix LLC | $41.14 | 2023-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Saluda Medical Americas, INC. | $39.02 | 2025 | Evoke |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tersera Therapeutics LLC | $38.55 | 2022-2023 | Xermelo |
| Mml US, INC. | $30.18 | 2025 | Reactiv8 |
| International Rehabilitative Sciences, INC | $29.60 | 2024-2025 | Rs 4i Plus Sequential Stimulator |
| Pharmacyclics LLC, An Abbvie Company | $28.53 | 2023 | Imbruvica, Epkinly |
| Almatica Pharma LLC | $26.81 | 2022 | |
| Amgen INC. | $22.12 | 2025 | Krystexxa |
| Grt US Holding, INC. | $21.91 | 2022 | |
| Si-Bone, INC. | $19.90 | 2023 | |
| Medtronic, INC. | $15.17 | 2025 | Inceptiv |
| Fidia Pharma USA INC. | $14.46 | 2023 | Triluron, Hymovis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.